{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:37:37Z","timestamp":1746495457461},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"no fundings received"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12664-016-0710-8","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T01:05:36Z","timestamp":1477443936000},"page":"445-449","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rectal GIST\u2014Outcomes and viewpoint from a tertiary cancer center"],"prefix":"10.1007","volume":"35","author":[{"given":"Saurabh","family":"Zanwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Ostwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anant","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avanish","family":"Saklani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukta","family":"Ramadwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh V.","family":"Shrikande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"710_CR1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","volume":"103","author":"B Nilsson","year":"2005","unstructured":"Nilsson B, Bumming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era\u2013a population-based study in western Sweden. Cancer. 2005;103:821\u20139.","journal-title":"Cancer"},{"key":"710_CR2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.21167","volume":"117","author":"G Tryggvason","year":"2005","unstructured":"Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG. Gastrointestinal stromal tumors in Iceland, 1990\u20132003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117:289\u201393.","journal-title":"Int J Cancer"},{"key":"710_CR3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","volume":"130","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466\u201378.","journal-title":"Arch Pathol Lab Med"},{"key":"710_CR4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3892\/mco.2012.25","volume":"1","author":"M Farid","year":"2013","unstructured":"Farid M, Lee MJ, Chew MH, et al. Localized gastrointestinal stromal tumor of the rectum: an uncommon primary site with prominent disease and treatment-related morbidities. Mol Clin Oncol. 2013;1:190\u20134.","journal-title":"Mol Clin Oncol"},{"key":"710_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cncr.23199","volume":"112","author":"RP Dematteo","year":"2008","unstructured":"Dematteo RP, Gold JS, Saran L, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer. 2008;112:608\u201315.","journal-title":"Cancer"},{"key":"710_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","volume":"23","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70\u201383.","journal-title":"Semin Diagn Pathol"},{"key":"710_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2407-11-72","volume":"11","author":"A Blesius","year":"2011","unstructured":"Blesius A, Cassier PA, Bertucci F, et al. Neoadjuvant imatinib inpatients with locally advanced non metastatic GIST in the prospective BFR14trial. BMC Cancer. 2011;11:72.","journal-title":"BMC Cancer"},{"key":"710_CR8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2407-12-90","volume":"12","author":"J Call","year":"2012","unstructured":"Call J, Walentas CD, Eickhoff JC, Scherzer N. Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry. BMC Cancer. 2012;12:90.","journal-title":"BMC Cancer"},{"key":"710_CR9","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1245\/s10434-013-3013-7","volume":"20","author":"P Rutkowski","year":"2013","unstructured":"Rutkowski P, Gronchi A, Hohenberger P, et al. Neoadjuvant imatinib in locallyadvanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20:2937\u201343.","journal-title":"Ann Surg Oncol"},{"key":"710_CR10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/COC.0b013e3182a78de9","volume":"38","author":"J Stiekema","year":"2015","unstructured":"Stiekema J, Kol S, Cats A, et al. Surgical treatment of gastrointestinal stromal tumors located in the stomach in the imatinib era. Am J Clin Oncol. 2015;38:502\u20137.","journal-title":"Am J Clin Oncol"},{"key":"710_CR11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jso.23562","volume":"109","author":"H Liu","year":"2014","unstructured":"Liu H, Yan Z, Liao G, Yin H. Treatment strategy of rectal gastrointestinal stromal tumor (GIST). J Surg Oncol. 2014;109:708\u201313.","journal-title":"J Surg Oncol"},{"key":"710_CR12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1245\/s10434-012-2647-1","volume":"20","author":"J Jakob","year":"2013","unstructured":"Jakob J, Mussi C, Ronellenfitsch U, et al. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Ann Surg Oncol. 2013;20:586\u201392.","journal-title":"Ann Surg Oncol"},{"key":"710_CR13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/bjs.9818","volume":"102","author":"MJ Wilkinson","year":"2015","unstructured":"Wilkinson MJ, Fitzgerald JE, Strauss DC, et al. Surgical treatment of gastrointestinalstromal tumour of the rectum in the era of imatinib. Br J Surg. 2015;102:965\u201371.","journal-title":"Br J Surg"},{"key":"710_CR14","doi-asserted-by":"crossref","first-page":"232531","DOI":"10.1200\/JCO.2005.05.3439","volume":"24","author":"C Raut","year":"2006","unstructured":"Raut C, Posner M, Desai J, et al. Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol. 2006;24:232531.","journal-title":"J Clin Oncol"},{"key":"710_CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/hupa.2002.123545","volume":"33","author":"CD Fletcher","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459\u201365.","journal-title":"Hum Pathol"},{"key":"710_CR16","first-page":"761576","volume":"2012","author":"C Doyon","year":"2012","unstructured":"Doyon C, Sid\u00e9ris L, Leblanc G, Leclerc YE, Boudreau D, Dub\u00e9 P. Prolonged therapy with imatinib mesylate before surgery for advanced gastrointestinal stromal tumor results of a phase II trial. Int J Surg Oncol. 2012;2012:761576.","journal-title":"Int J Surg Oncol"},{"key":"710_CR17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.sla.0000242710.36384.1b","volume":"245","author":"A Gronchi","year":"2007","unstructured":"Gronchi A, Fiore M, Miselli F, et al. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced\/metastatic GIST. Ann Surg. 2007;245:341\u20136.","journal-title":"Ann Surg"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-016-0710-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:58:18Z","timestamp":1657533498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-016-0710-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1007\/s12664-016-0710-8","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,26]]}}}